Synthesis and characterization of nido-carborane-cobalamin conjugates

Nuclear Medicine and Biology

Volumn 27, Issue 1, 2000, Pages 89-92

  Hogenkamp, Harry P C ^a   Collins, Douglas A ^b   Live, David ^a   Benson, Linda M ^b   Naylor, Stephen ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Boron neutron capture therapy (BNCT); Boronated vitamin B12; Cyanocobalamin nido carborane conjugates; Vitamin B12

Indexed keywords

BORANE DERIVATIVE; BORON; COBALAMIN DERIVATIVE; CYANOCOBALAMIN CO 57;

ARTICLE; CANCER THERAPY; CONJUGATE; DRUG ACTIVITY; DRUG BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RESONANCE;

BORON COMPOUNDS; COBALT RADIOISOTOPES; HUMANS; NEUTRON CAPTURE THERAPY; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN B 12;

EID: 0033951571     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00081-5     Document Type: Article

References (11)

1. Anton D.L., Hogenkamp H.P.C., Walker T.E., Matwiyoff N.A. Carbon-13 nuclear magnetic resonance studies of the monocarboxylic acids of cyanocobalamin. Assignments of the b-, d-, and e-monocarboxylic acids. J. Am. Chem. Soc. 102:1980;2215-2219.
2. Barth R.F., Soloway A.H., Fairchild R.G. Boron neutron capture therapy of cancer. Cancer Res. 50:1997;1061-1070.
3. Collins D.A., Hogenkamp H.P.C. Transcobalamin II receptor imaging via radiolabeled diethylenetriaminepentaacetate cobalamin analogs. J. Nucl. Med. 38:1997;717-723.
4. Collins D.A., Hogenkamp H.P.C., Gebhard M. Tumor imaging via In-111-DTPA-adenosylcobalamin. Mayo Clin. Proc. 74:(7):1999;687-691.
5. 12. Acta Radiologica Supplementum. 284:1968;3-80.
6. Hawthorne M.F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem. Int. Ed. Engl. 32:1993;950-984.
7. Hawthorne M.F., Shelly K. Liposomes as delivery vehicles for boron agents. J. Neurooncol. 33:1997;53-58.
8. Hogenkamp H.P.C., Collins D.A. The synthesis and in vitro biological activity of cobalamin-diethylenetriaminepentaacetate complexes. Biofactors. 5:1996;180-182.
9. Kahl S.B., Joel D.D., Nawrocky M.M., Micca P.L., Tran K.P., Finkel G.C., Slatkin D.N. Uptake of a nido-carboranyl porphyrin by human glioma xenografts in athymic nude mice and by syngeneic ovarian carcinomas in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 87:1990;7265-7269.
10. Nakanishi A., Guan L., Kane R.R., Kasamatsu H., Hawthorne M.F. Toward a cancer therapy with boron-rich oligomeric phosphate diesters that target the cell nucleus. Proc. Natl. Acad. Sci. USA. 96:1999;238-241.
11. Sjöberg S., Carlsson J., Chaneolhosseini H., Gedda L., Hartmat T., Malquiest J., Naeslund C., Olsson P., Tjarks W. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy. J. Neurooncol. 33:1997;41-52.